Cell degradation is topic of science review

November 30, 2000

Molecular biologist discusses role of autophagy

Autophagy, the process of self-digestion of cell components through the action of enzymes within a cell, plays a vital role in cell maintenance and development, but in recent years has also been linked to a growing number of human diseases, including neurodegenerative conditions, cardiovascular disease and breast cancer.

In the Dec. 1, 2000 issue of the journal Science, UCSD professor of cellular and molecular medicine and Howard Hughes Medical Institute investigator Scott D. Emr, Ph.D., reviews recent findings regarding autophagy and advances made in identifying its molecular components.

Along with co-author Daniel J. Klionsky from the University of Michigan, Emr notes that autophagy, the breakdown and recycling of cellular material, is seen in yeast, plants and animals. Although first identified more than 20 years ago, scientific interest in autophagy was fairly modest until the identification about five years ago of several of the molecular components underlying this important process. Since then, some 30 genes have been identified as part of the autophagy pathway. Within the past two years, researchers have identified a link between decreased levels of one of these genes, called beclin 1, and breast cancer.

"There are many lines of evidence that connect autophagy to human disease," Emr says. Lower levels of autophagy genes have been linked to cancer and heart disease, while elevated expression of autophagy is associated with neurodegenerative diseases such as Parkinson's.

In the Science review, Emr and Klionsky note that several questions remain for researchers, including the mechanism by which cells sense the need for autophagy and the specific roles of genes within the autophagy pathway.
-end-


University of California - San Diego

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.